APA
Frankova S., Jirsa M., Merta D., Neroldova M., Urbanek P., Senkerikova R., Spicak J. & Sperl J. (20151231). USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study. : Therapeutics and clinical risk management.
Chicago
Frankova Sona, Jirsa Milan, Merta Dusan, Neroldova Magdalena, Urbanek Petr, Senkerikova Renata, Spicak Julius and Sperl Jan. 20151231. USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study. : Therapeutics and clinical risk management.
Harvard
Frankova S., Jirsa M., Merta D., Neroldova M., Urbanek P., Senkerikova R., Spicak J. and Sperl J. (20151231). USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study. : Therapeutics and clinical risk management.
MLA
Frankova Sona, Jirsa Milan, Merta Dusan, Neroldova Magdalena, Urbanek Petr, Senkerikova Renata, Spicak Julius and Sperl Jan. USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study. : Therapeutics and clinical risk management. 20151231.